Molecular carcinogenesis delves into the intricate mechanisms underlying cancer development at the molecular level. It explores how genetic mutations, epigenetic alterations, and environmental factors converge to initiate and propagate tumorigenesis. By dissecting the molecular pathways involved, researchers aim to uncover novel targets for cancer therapy and develop precision medicine approaches tailored to individual patients. From identifying oncogenes and tumor suppressor genes to unraveling the complex interplay between signaling pathways, molecular carcinogenesis provides crucial insights into cancer biology. Moreover, advancements in technologies such as next-generation sequencing and single-cell analysis have revolutionized our understanding of tumor heterogeneity and clonal evolution, offering new avenues for therapeutic intervention. Ultimately, by deciphering the molecular intricacies of carcinogenesis, scientists strive to improve cancer diagnosis, treatment, and patient outcomes.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States